C
Cardio Diagnostics Holdings Inc (CDIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$1.76
+0.09 (+5.39%)
Market Cap: $4.94M
Last updated: Oct 16, 2026 at 1:54 PM ET
Earnings
Performance (10Y)
Beat Rate
31%(4/13)Avg Surprise
-129.46%Key Metrics
Technical Indicators Dashboard
Moving Averages
SMA 10$1.87
SMA 20$1.89
SMA 50$1.92
SMA 200$2.11
EMA 10$1.82
EMA 20$1.87
EMA 50$1.90
EMA 200$2.45
MACD
Line: -0.04Signal: -0.02Hist: -0.03
ADX
ADX: 26.9+DI: 20.6-DI: 22.0
Aroon & PSAR
Aroon Up68.0
Aroon Down88.0
PSAR$2.15
Bollinger Bands
Upper Band$2.09
Lower Band$1.70
%B Position2018%(Upper)
Band Width0.15
RSI (14-Day)
Neutral
41.3
Momentum Oscillators
Stoch %K12.5
Stoch %D13.5
Williams %R-81.7
ROC (10d)-8.3%
Momentum-0.16
CCI (20d)-158.7
MFI (14d)34.8
Volatility Measures
ATR (14d)$0.13(7.7%)
StdDev (20d)0.10
Hist Vol48.8%(High)
Volume Flow
VWAP$1.75
OBV147.7M
AD Line8.2B
CMF (20d)-0.369
Volume Metrics
Avg Vol (20d)31.8K
Vol Ratio0.9x
VWMA (20d)$1.90
Pivot Points
R3$1.85
R2$1.82
R1$1.74
Pivot Point$1.71
S1$1.63
S2$1.60
S3$1.52
Advanced Oscillators
TSI-12.45
Ultimate Osc29.7
KST-45.07
Financial Data
Related GNG Research
No research available
Be the first to write about CDIO
News
CDIO Valuation and Fair Value
- P/E
- -0.6x
- P/B
- 0.7x
CDIO Profitability: Margins, ROIC and FCF
- Gross margin
- 100.0%
- Operating margin
- -27950.0%
- Net margin
- 0.0%
- ROE
- -75.4%
- FCF margin
- -40425.3%
CDIO Competitors
Sector: Healthcare
CDIO Bull Case vs Bear Case
Bear case
- CDIO beat EPS estimates in 25.0% of its last 8 reported quarters.
- CDIO's quarterly revenue changed -28.3% year over year.
CDIO Earnings: Beat Rate and Next Report
- Beat rate
- 2 of 8 quarters (25.0%)
- Average surprise
- -158.2%
Frequently Asked Questions About CDIO
Does CDIO pay dividends?
Cardio Diagnostics Holdings Inc (CDIO) does not currently pay a regular dividend.
What is CDIO's market cap?
Cardio Diagnostics Holdings Inc (CDIO) has a market capitalization of $4.94M with a current stock price of $1.76.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.